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Pemphigus herpetiformis (PH) is one of the less common forms of pemphigus. PH in children is unreported. We describe a case of
a child who developed PH. Observation. A 12-year-old boy was seen at our department with erosive plaques, vesicles, and crusted
cutaneous lesions associated with severe itching persisting for six months. Histologic examination showed an intraepidermal bulla
containing rare acantholytic epidermal cells with eosinophilic spongiosis. Direct immunoﬂuorescence demonstrated intercellular
Ig G and C3 deposit. The serum titer of antibodies against intercellular epidermal was 1/200UI/l. Diagnosis of PH was made, and
treatment with Dapsone 2mg/kg per day resulted in total clinical remission. However, two months later, new vesicles reappeared
and treatment was begun with prednisone at a dose of 2mg/kg daily. There was a very good response. Discussion. Childhood
pemphigus herpetiformis is a rare disease, often initially misdiagnosed. It must not be forgotten that the disease is a possible cause
of erosive mucocutaneous disease in children.
1.Introduction
The pemphigus diseases, which include some of the most
severebullousautoimmuneskinreactions,areseenpredomi-
nantly in middle-aged and elderly individuals. Only endemic
pemphigus foliaceus in South America most frequently
aﬀects juveniles and children. All nonendemic pemphigus
diseases, including paraneoplastic pemphigus, have been
reported to occur in adolescents and even very rarely in
children younger than 10 years.
Pemphigus herpetiformis (PH) is considered a variant of
pemphigus displaying clinical features similar to dermatitis
herpetiformis and a diverse histopathologic pattern with
intraepidermal and subcorneal microabscesses, eosinophilic
spongiosis, or superﬁcial bullae with usually scant acan-
tholytic cells [1, 2]. The clinical picture is variable, often with
coalescent annular or gyrate vesiculopustular lesions. The
diagnosis is based on detection of Ig G antikeratinocyte cell
surface antibodies, both bound in vivo and in circulation.
In the literature, few cases of pemphigus are reported in
children. This rarity in childhood may be only apparent as a
result of its diﬃcult diagnosis. Pemphigus herpetiformis in a
child is unreported. We describe a case that developed PH.
2. Observation
An 12-year-old boy was seen at our department in March,
2007, with erosive plaques, vesicles, bulls, and crusted lesions
associated with severe itching persisting for six months. The
boy’sfamilyhistoryandpersonalhistorywereunremarkable,
and his growth and development had proceeded normally.
On examination, we observed vesicular, bullous lesions,
some having clear contents and some being purulent with
erosive arciform plaques and crusted lesions (Figures 1(a)
and 1(b)). They were seen especially over the back, buttocks,
chest, abdomen legs, and arms. The face, scalp, palms,
and soles were spared. The mucosa and nails were normal.
Nikolsky’s sign was negative. Results of physical examination
were completely normal, except for the cutaneous ﬁndings.
Laboratory values were within normal limits. Histologic
examination of one of the lesions showed an intraepi-
dermal bulla containing rare acantholytic epidermal cells,
eosinophil and neurophil cells. The lower epidermis showed
eosinophilic spongiosis and focal acanthosis. The superticia1
and reticular dermis had an inﬂammatory inﬁltrate of
eosinophile and neutrophile around some of the blood
vessels (Figures 2(a) and 2(b)). Direct immunoﬂuorescence2 ISRN Pediatrics
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Figure 1:(a)Erosiveplaqueonthearminpemphigusherpetiformis.(b)Arciformpatternofpostbullouslesioninpemphigusherpetiformis.
(a) (b)
Figure 2: Histopathologic features. Intraepidermal bulla ﬁlled with neutrophils and numerous eosinophils. Single acantholytic cells are
seen. Lower epidermis: eosinophilic spongiosis (HE ×40) Intraepidermal bulla ﬁlled with neutrophils and eosinophils, characteristic of
eosinophilic spongiosis (HE ×200).
demonstrated intercellular IgG and complement C3. IgA
intercellular deposits on epidermis were not seen (Figures
3(a) and 3(b)). The serum titer of antibodies against inter-
cellular epidermal was positive (1/200UI/l). Antiendomysial
and antigliadin antibodies serum titers were negative. A
diagnosis of PH was made, and treatment with Dapsone
2mg/kg per day resulted in total clinical remission. However,
two months later, new vesicles reappeared and treatment was
begun with prednisone at a dose of 2mg/kg daily. There
was a very good response; lesions regressed slowly, until they
completely disappeared after 4 weeks of treatment. The daily
dose of the prednisone was lowered gradually according to
the clinical improvement, and, at the time of this report, one
year after onset of the disease the skin involvement was being
kept under control on a low maintenance dose of 10mg of
prednisone daily.
3. Discussion
Autoimmune blistering diseases are extremely rare in chil-
dren [3]. A review from a paediatric dermatology referral
center for a population of 4 million people identiﬁed only 23
cases of immunobullous disease in patients less than 18 years
of age over a 16-year period [4]. Of all the immunobullous
disorders in children, pemphigus comprises a minority. A
recent review of pemphigus vulgaris (PV) in children found
only 46 casesreported in the literature [5].Cases withPH are
quite uncommon.ISRN Pediatrics 3
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Figure 3: (a, b) Direct immunoﬂuorescence. IgG and C3 cell surface deposits throughout the whole epidermis.
Pemphigus herpetiformis (PH) was ﬁrst introduced by
Jablonska and colleagues [1]a sav a r i a n to fp e m p h i g u s .
Various terms have been used to describe this condition,
such as acantholytic herpetiform dermatitis [6], pemphigus
controlled by sulfapyridine [7], and mixed bullous dis-
ease [8]. Clinical manifestations consist of erythematous,
urticarial plaques, and vesicles that present in herpetiform
arrangement[8].HistologicalﬁndingsofHParevariableand
includeeosinophilicspongiosisandsubcornealpustuleswith
minimal or no apparent acantholysis [9, 10]. Immunoﬂuo-
rescence ﬁndings show that most patients with PH have IgG
antibodies against keratinocyte cell surfaces [9]. Dapsone
is the ﬁrst choice of drug in the PH treatment given as
monotherapy or combined with systemic corticosteroids [2].
In most reported cases, the use of systemic corticosteroids
was necessary to achieve clinical remission [2]. In some
cases, however, the use of immunosuppressive drugs such
as azathioprine and cyclophosphamide becomes necessary to
induce clinical remission or to help in reducing steroid dose
so that its collateral eﬀects are minimized [2]. Its position
in the pemphigus group remains controversial. Based on
its clinical features, some researchers reported the disease
as a distinct entity and consider it to be diﬀerent from
classic pemphigus because of its clinical peculiarity and
benign course. However, others described it as a variant of
pemphigus foliaceus (PF) or PV [9].
We believe the boy presents a pemphigus herpetiformis
variant because of the clinical features of dermatitis herpeti-
formis (vesicles, bulls, and itching) and the immunologic
(IgG and C3 deposit on intercellular epidermal) and his-
tological features (intraepidermal bulls and acantholysis) of
pemphigus with an eosinophilic spongiosis.
Various types of pemphigus including vulgaris, foliaceus,
erythematosus,vegetans, and paraneoplastic pemphigus can
be seen in childhood [10]. We could not ﬁnd reports of pem-
phigus herpetiformis in childhood other than our patient.
Childhood pemphigus herpetiformis is a rare disease, often
initiallymisdiagnosed.Thediseasemustnotbeforgottenasa
possible cause of erosive mucocutaneous disease in children.
It is important that antibody titers, management plans,
and outcomes for this disease be reported so that greater
knowledge of the eﬀects of various treatment regimens can
be obtained.
Abbreviations
Dsg 3: Desmoglein 3
Dsg 1: Desmoglein 1
PF: Pemphigus foliaceus
PH: Pemphigus herpetiformis
PV: Pemphigus vulgaris.
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